Expedite Research Timelines, Optimize Research Design, and Improve Patient Outcomes Using a New Source of Research-Grade Data

The development of technology and comprehensive access to EHRs, claims, and patient reported outcomes (PRO) data has swiftly changed how we assess clinical research today. Benchmarking, clinical trial recruitment, and real-world evidence increasingly rely on real-world data for important decision making by physicians, pharmaceutical companies, and regulators, making robust data paramount in the improvement of patient health outcomes.

However, the uptake in technology that makes access to patients’ data readily accessible is biased towards those institutions with advanced IT and research capabilities. This limitation leads to overrepresentation by institutions such as academic medical centers (AMCs) and a lack of diversity in available patient data—as AMCs are most often located in urban areas, leaving the community and rural hospitals at a disadvantage.

此外，当单独分析时，从更多主要研究来源收集的数据不能捕捉患者的整个旅程，可能导致不准确的结论。此外，这种隔离暴露了患者护理和临床研究方面的其他差距，包括临床研究的公平性和包容性，真正的端到端临床试验解决方案，以及以患者为中心的结果。2022卡塔尔世界杯赛程表时间

Real-World Data, Technology, and the Patient Journey

With advances in technology for both the provider and patient and the ability to aggregate disparate data sources, the disparities emerging in recent years shouldn’t exist. The real-world data ecosystem can address diversity by supplementing data from AMCs with rural sites, community sites, and research-naïve sites.

This data aggregation enables clinical research solutions that swiftly identify and recruit patients through clinician-tested technology and patient-tested apps. As a result, research-naïve sites can focus on patient care and participate in clinical trials, then follow this patient journey through and post-clinical trial to provide real-world evidence that supports new strategies to improve patient health outcomes.

Through existing relationships with healthcare systems, Health Catalyst is uniquely positioned to address these industry data challenges.

Bringing a More Comprehensive Solution to the Market

Health Catalyst is committed to supporting life sciences organizations in expediting research timelines, optimizing research design, and improving patient outcomes through access to a new source of research-grade data, rapid cohort creation, automated patient engagement, and augmented intelligence.

Tap into a New Source of Research-Grade Data

Touchstone®为美国30%的医疗保健机构的客户提供了访问各种患者级研究级数据的净新来源。这包括来自传统amc之外的数据，包括HCOs和社区医院。试金石数据包括人口统计、临床、索赔和注册数据，以及其他来源，使客户能够支持更多的用例。

These data sources provide geographically and demographically diverse data that is more representative of healthcare across the United States. This greater diversity of sources enables improved representation in clinical research and trials, leading to better health equity and patient outcomes. Furthermore, Health Catalyst’s interactive healthcare system relationships enable Touchstone to curate unique data needs for customers that may be missing from existing data sets generated outside of Health Catalyst.

Recognize a Faster Time-to-Value for Research Activities

The Touchstone Match™ solution is an AI-powered, real-world data solution, that puts a new source of diverse, research-grade clinical data at researchers’ fingertips, improving decision making and accelerating the success of the clinical development life cycle.

Touchstone Match provides customers with the ability to:

• Implement one user-friendly solution for feasibility research, real-world data and trial startup for research-naïve sites.
• Build and run queries to quickly identify patient cohorts.
• Quickly drill into patient-level and longitudinal data, providing novel insights into known populations.
• Optimize protocol design with analytics, including advanced AI and ML capabilities for rare and unstructured insights.
• 认识到一个更准确的可行性评估，减少招募时间，并加速第一个患者(FPI)。

Implement AI-Driven Insights to Power Research Use Cases

Healthcare.AI™ Expert Services support the effective use of AI in research use cases. These professional services also include access to data scientists and subject matter experts who can review data sets and evaluate the quality of a query and underlying data, as well as complete feasibility assessments on the behalf of customers.

Establish New Industry Connections and Collaborations

Heal世界杯葡萄牙vs加纳即时走地th Catalyst研究网络™为客户提供了扩大行业联系和跨供应商、生物制药公司和合同研究组织(CROs)合作的机会。健康催化世界杯葡萄牙vs加纳即时走地剂研究网络由一个精心策划的国家数据生态系统组成，用于思想领导和相互知识交流，通过下一代见解转变护理提供和药物开发研究。

Looking Forward: What’s Next

Providing customers with access to a new source of data and supporting the identification of patients for clinical research is just the first step. Health Catalyst continues to look for new ways to solve the industry’s biggest challenges.

Health Catalyst continues to onboard existing customers into the Health Catalyst Research Network, growing the data available within Touchstone. In addition to onboarding these existing customers, Health Catalyst is actively expanding industry relationships to include new customers.

To address the industry challenge of expediting the patient recruitment process, Health Catalyst is integrating existing research solutions that will enable real-time, automated, clinical trial patient recruitment.

Additional Reading

Would you like to learn more about this topic? Here are some articles we suggest:

• No Going Back: Seven Trends Have Changed the Life Sciences Industry Forever
• Delivering Precision Medicine: How Data Drives Individualized Healthcare
• Digital Patient Engagement: Best Practices to Drive an Optimal Patient Experience and Outcomes
• How a U.S. COVID-19 Data Registry Fuels Global Research
• Extended Real-World Data: The Life Science Industry’s Number One Asset